HCW Biologics Inc (HCWB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.73M
Last updated: Nov 17, 2026 at 4:33 PM ET
HCW Biologics Inc (HCWB) Statistics
HCW Biologics (HCWB) has a market cap of $1.73M and an enterprise value of $7.61M. Revenue grew 1502.05% over the last 12 months from the 12 months before. Its net debt of $5.88M equals 339.89% of its market cap.
Total Valuation
Enterprise value is 339.89% above the market cap, as debt exceeds cash.
| Market Cap | $1.73M |
|---|---|
| Enterprise Value | $7.61M |
| Latest price (Nov 17, 2026) | $0.76 |
Key Dates
| Last Earnings Date | Nov 16, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.2x and 0.2x.
| P/S Ratio | 0.2x |
|---|---|
| Forward P/S | 0.3x |
| P/B Ratio | 0.2x |
Price Statistics
The stock is down 95.79% over 52 weeks and trades 47.59% below its 50-day average.
| Beta (1Y) | 1.12 |
|---|---|
| 52-Week Change | -95.79% |
| 1-Month Change | -38.41% |
| 3-Month Change | -67.07% |
| 6-Month Change | -88.09% |
| 5-Year Change | -99.90% |
| Total Return (1Y) | -95.79% |
| Total Return (3Y CAGR) | -85.76% |
| Total Return (5Y CAGR) | -74.40% |
| Max Drawdown (1Y) | -95.87% |
| Max Drawdown (3Y) | -99.82% |
| Sharpe Ratio (1Y) | -1.41 |
| Correlation with SPY (1Y) | 0.07 |
| 50-Day Average | $1.45 |
| 200-Day Average | $3.72 |
| 52-Week Range | $0.74 to $23.94 |
| RSI (14 Days) | 23.5 |
| Average Volume (20 Days) | 43.52K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.07x current liabilities, and total debt is 1.00x shareholder equity.
| Current Ratio | 0.07x |
|---|---|
| Quick Ratio | 0.07x |
| Debt / Equity | 1.00x |
| Interest Coverage | 1.67x |
Returns and Efficiency
Return on invested capital is -51.63% and return on equity is -62.29% over the last 12 months.
| Return on Equity (ROE) | -62.29% |
|---|---|
| Return on Assets (ROA) | -16.92% |
| Return on Invested Capital (ROIC) | -51.63% |
| ROA (5Y Average) | -55.06% |
| Asset Turnover | 0.27x |
| Receivables Turnover | 732.86x |
Scores
HCWB has an Altman Z-Score of -7.95, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -7.95 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was $6.76M over the last 12 months.
| Revenue | $6.76M |
|---|---|
| Revenue Growth (YoY) | +1502.05% |
| Gross Profit | $6.47M |
| Operating Income | -$6.96M |
| Pretax Income | -$3.84M |
| Net Income | -$4.25M |
| Reported EPS (TTM) | -$16.83 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 27.14% of the $25.13M in total assets.
| Cash and Equivalents | $955.46K |
|---|---|
| Total Debt | $6.83M |
| Net Debt | $5.88M |
| Net Debt Per Share | $2.80 |
| Working Capital | -$16.33M |
| Shareholder Equity | $6.82M |
| Book Value Per Share | $3.25 |
| Total Assets | $25.13M |
| Total Liabilities | $18.30M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$11.52M |
|---|---|
| FCF Per Share | -$5.15 |
| Depreciation and Amortization | $546.16K |
| Share Repurchases | $406.07K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -102.96%.
| Gross Margin | 95.72% |
|---|---|
| Operating Margin | -102.96% |
| Pretax Margin | -56.77% |
| Net Margin | -62.87% |
Growth
Revenue fell 79.94% a year over 3 years.
| Revenue Growth (3Y CAGR) | -79.94% |
|---|---|
| Revenue Growth (5Y CAGR) | -57.90% |
Dividends and Yields
HCWB does not pay a dividend.
| Buyback Yield | -801.32% |
|---|---|
| Shareholder Yield | -801.32% |
Stock Splits
The last split was a 1-for-6 reverse split on Jun 30, 2026.
| Last Split Date | Jun 30, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:6 |
Peer Position
Against 5 similar companies, HCWB has the 3rd highest ROIC.
ROICPeer median -61.86%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -100.00%
| ROIC | -51.63% vs -61.86% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +1502.05% vs -100.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 12215.61% a year over the next fiscal year.
| Revenue Growth Forecast (1Y CAGR) | +12215.61% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About HCWB
What is HCWB's market cap?
HCW Biologics has a market cap of $1.73M. Its enterprise value, which adds debt and subtracts cash, is $7.61M.
How many shares of HCWB are outstanding?
HCW Biologics has 2.10M shares outstanding.
Does HCWB pay a dividend?
No. HCW Biologics does not pay a dividend.
How much debt does HCWB have?
HCW Biologics has $6.83M of total debt and $955.46K of cash and equivalents, a net debt position of $5.88M.
HCWB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors